Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor
Natural killer (NK) cells are an important effector cell type for adoptive cancer immunotherapy. Similar to T cells, NK cells can be modified to express chimeric antigen receptors (CARs) to enhance antitumor activity, but experience with CAR-engineered NK cells and their clinical development is stil...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2015
|
| In: |
Molecular therapy
Year: 2014, Volume: 23, Issue: 2, Pages: 330-338 |
| ISSN: | 1525-0024 |
| DOI: | 10.1038/mt.2014.219 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1038/mt.2014.219
|
| Author Notes: | Kurt Schönfeld, Christiane Sahm, Congcong Zhang, Sonja Naundorf, Christian Brendel, Marcus Odendahl, Paulina Nowakowska, Halvard Bönig, Ulrike Köhl, Stephan Kloess, Sylvia Köhler, Heidi Holtgreve-Grez, Anna Jauch, Manfred Schmidt, Ralf Schubert, Klaus Kühlcke, Erhard Seifried, Hans G. Klingemann, Michael A. Rieger, Torsten Tonn, Manuel Grez, Winfried S. Wels |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1557310130 | ||
| 003 | DE-627 | ||
| 005 | 20230426153702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170428r20152014xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/mt.2014.219 |2 doi | |
| 035 | |a (DE-627)1557310130 | ||
| 035 | |a (DE-576)487310136 | ||
| 035 | |a (DE-599)BSZ487310136 | ||
| 035 | |a (OCoLC)1340973185 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schönfeld, Kurt |d 1980- |e VerfasserIn |0 (DE-588)131694073 |0 (DE-627)51272492X |0 (DE-576)298679108 |4 aut | |
| 245 | 1 | 0 | |a Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor |c Kurt Schönfeld, Christiane Sahm, Congcong Zhang, Sonja Naundorf, Christian Brendel, Marcus Odendahl, Paulina Nowakowska, Halvard Bönig, Ulrike Köhl, Stephan Kloess, Sylvia Köhler, Heidi Holtgreve-Grez, Anna Jauch, Manfred Schmidt, Ralf Schubert, Klaus Kühlcke, Erhard Seifried, Hans G. Klingemann, Michael A. Rieger, Torsten Tonn, Manuel Grez, Winfried S. Wels |
| 264 | 1 | |c 2015 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 9 December 2014 | ||
| 500 | |a Gesehen am 28.04.2017 | ||
| 520 | |a Natural killer (NK) cells are an important effector cell type for adoptive cancer immunotherapy. Similar to T cells, NK cells can be modified to express chimeric antigen receptors (CARs) to enhance antitumor activity, but experience with CAR-engineered NK cells and their clinical development is still limited. Here, we redirected continuously expanding and clinically usable established human NK-92 cells to the tumor-associated ErbB2 (HER2) antigen. Following GMP-compliant procedures, we generated a stable clonal cell line expressing a humanized CAR based on ErbB2-specific antibody FRP5 harboring CD28 and CD3ζ signaling domains (CAR 5.28.z). These NK-92/5.28.z cells efficiently lysed ErbB2-expressing tumor cells in vitro and exhibited serial target cell killing. Specific recognition of tumor cells and antitumor activity were retained in vivo, resulting in selective enrichment of NK-92/5.28.z cells in orthotopic breast carcinoma xenografts, and reduction of pulmonary metastasis in a renal cell carcinoma model, respectively. γ-irradiation as a potential safety measure for clinical application prevented NK cell replication, while antitumor activity was preserved. Our data demonstrate that it is feasible to engineer CAR-expressing NK cells as a clonal, molecularly and functionally well-defined and continuously expandable cell therapeutic agent, and suggest NK-92/5.28.z cells as a promising candidate for use in adoptive cancer immunotherapy. | ||
| 534 | |c 2014 | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Breast Neoplasms | |
| 650 | 4 | |a Cell Line, Transformed | |
| 650 | 4 | |a Cell Line, Tumor | |
| 650 | 4 | |a Clonal Evolution | |
| 650 | 4 | |a Cytotoxicity, Immunologic | |
| 650 | 4 | |a Disease Models, Animal | |
| 650 | 4 | |a Epitopes, T-Lymphocyte | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Gene Expression | |
| 650 | 4 | |a Genetic Vectors | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Immunophenotyping | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Killer Cells, Natural | |
| 650 | 4 | |a Lentivirus | |
| 650 | 4 | |a Lymphocyte Culture Test, Mixed | |
| 650 | 4 | |a Neoplasms | |
| 650 | 4 | |a Phenotype | |
| 700 | 1 | |a Holtgreve-Grez, Heidi |e VerfasserIn |0 (DE-588)1080249680 |0 (DE-627)844087459 |0 (DE-576)453430783 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Schmidt, Manfred |d 1967-2022 |e VerfasserIn |0 (DE-588)122922301 |0 (DE-627)706092430 |0 (DE-576)293477620 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy |d Amsterdam : Elsevier, 2000 |g 23(2015), 2, Seite 330-338 |h Online-Ressource |w (DE-627)320415198 |w (DE-600)2001818-6 |w (DE-576)104344695 |x 1525-0024 |7 nnas |a Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor |
| 773 | 1 | 8 | |g volume:23 |g year:2015 |g number:2 |g pages:330-338 |g extent:9 |a Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/mt.2014.219 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170428 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 122922301 |a Schmidt, Manfred |m 122922301:Schmidt, Manfred |d 140000 |e 140000PS122922301 |k 0/140000/ |p 14 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |e 910000PJ1025525140 |e 911500PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |p 13 | ||
| 998 | |g 1080249680 |a Holtgreve-Grez, Heidi |m 1080249680:Holtgreve-Grez, Heidi |d 910000 |d 911500 |e 910000PH1080249680 |e 911500PH1080249680 |k 0/910000/ |k 1/910000/911500/ |p 12 | ||
| 999 | |a KXP-PPN1557310130 |e 2967499447 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Kurt Schönfeld, Christiane Sahm, Congcong Zhang, Sonja Naundorf, Christian Brendel, Marcus Odendahl, Paulina Nowakowska, Halvard Bönig, Ulrike Köhl, Stephan Kloess, Sylvia Köhler, Heidi Holtgreve-Grez, Anna Jauch, Manfred Schmidt, Ralf Schubert, Klaus Kühlcke, Erhard Seifried, Hans G. Klingemann, Michael A. Rieger, Torsten Tonn, Manuel Grez, Winfried S. Wels"]},"note":["Published online: 9 December 2014","Gesehen am 28.04.2017"],"recId":"1557310130","id":{"doi":["10.1038/mt.2014.219"],"eki":["1557310130"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedDisp":"2015","dateIssuedKey":"2015"}],"physDesc":[{"extent":"9 S."}],"person":[{"family":"Schönfeld","display":"Schönfeld, Kurt","given":"Kurt","role":"aut"},{"role":"aut","given":"Heidi","display":"Holtgreve-Grez, Heidi","family":"Holtgreve-Grez"},{"given":"Anna","display":"Jauch, Anna","family":"Jauch","role":"aut"},{"role":"aut","display":"Schmidt, Manfred","family":"Schmidt","given":"Manfred"}],"title":[{"title_sort":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor","title":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor"}],"relHost":[{"recId":"320415198","pubHistory":["1.2000 -"],"note":["Gesehen am 28.05.2020"],"disp":"Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorMolecular therapy","part":{"year":"2015","extent":"9","issue":"2","volume":"23","pages":"330-338","text":"23(2015), 2, Seite 330-338"},"title":[{"title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy","title_sort":"Molecular therapy"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Society of Gene Therapy","role":"isb"}],"id":{"zdb":["2001818-6"],"issn":["1525-0024"],"eki":["320415198"]},"language":["eng"],"origin":[{"publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla.","dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press"}]}]} | ||
| SRT | |a SCHOENFELDSELECTIVEI2015 | ||